Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Professional Diversity Network | IPDN | Nov 21, 2024 | 0.75 | +2.47 |
Proficient Auto Logistics | PAL | Nov 21, 2024 | 9.54 | +1.60 |
Profire Energy | PFIE | Nov 21, 2024 | 2.52 | 0.00 |
Profound Medical | PROF | Nov 21, 2024 | 7.52 | -2.21 |
ProFrac A | ACDC | Nov 21, 2024 | 7.55 | +5.74 |
PROG | PRG | Nov 21, 2024 | 46.34 | -1.36 |
Progress Software | PRGS | Nov 21, 2024 | 68.73 | +2.41 |
Progressive | PGR | Nov 21, 2024 | 263.44 | +2.50 |
Progyny | PGNY | Nov 21, 2024 | 14.97 | +7.08 |
ProKidney | PROK | Nov 21, 2024 | 1.74 | +5.45 |
Prologis | PLD | Nov 21, 2024 | 113.97 | -0.50 |
ProMIS Neurosciences | PMN | Nov 21, 2024 | 0.95 | -4.23 |
PropertyGuru | PGRU | Nov 21, 2024 | 6.63 | 0.00 |
ProPetro | PUMP | Nov 21, 2024 | 8.22 | +5.25 |
ProPhase Labs | PRPH | Nov 21, 2024 | 0.78 | +1.56 |
ProQR Therapeutics | PRQR | Nov 21, 2024 | 3.61 | -1.63 |
PROS | PRO | Nov 21, 2024 | 23.63 | +4.93 |
ProShares Bitcoin Strategy ETF | BITO | Nov 21, 2024 | 26.43 | +3.97 |
Proshares Ultra FTSE Europe | UPV | Nov 21, 2024 | 56.31 | -0.25 |
ProShares UltraShort Bloomberg Natural Gas | KOLD | Nov 21, 2024 | 55.40 | -5.36 |
Proshares Ultrashort FTSE Europe | EPV | Nov 21, 2024 | 41.08 | -0.92 |
Prospect Capital | PSEC | Nov 21, 2024 | 4.65 | +1.31 |
Prospect Capital A Pref | PSEC-A | Nov 21, 2024 | 19.05 | +2.97 |
Prosperity Bancshares | PB | Nov 21, 2024 | 82.34 | +0.78 |
Protagenic Therapeutics | PTIX | Nov 21, 2024 | 0.61 | +2.17 |
Protagonist Therapeutics | PTGX | Nov 21, 2024 | 41.65 | +2.46 |
Protalix Bio Therapeutics | PLX | Nov 21, 2024 | 1.66 | -1.78 |
Protara Therapeutics | TARA | Nov 21, 2024 | 2.29 | -0.87 |
Prothena | PRTA | Nov 21, 2024 | 14.44 | +0.28 |
Proto Labs | PRLB | Nov 21, 2024 | 39.74 | +1.25 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.